Meeting with Hildegard Bentele (Member of the European Parliament) and 7 other interest representatives

8 Oct 2025 · Biotech

Response to Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices as regards simplification and burden reduction

3 Oct 2025

Meeting with Olivier Chastel (Member of the European Parliament)

23 Sept 2025 · APAs briefing session on Biotech Act

Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament, Shadow rapporteur)

10 Sept 2025 · Meeting CMA

Meeting with Aurelijus Veryga (Member of the European Parliament)

16 Jul 2025 · Innovative Therapies and Public Health Challenges

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

6 Jun 2025

Meeting with Marco La Marca (Cabinet of Commissioner Dubravka Šuica) and 14 other interest representatives

6 May 2025 · Demographic Policy

Meeting with Ingeborg Ter Laak (Member of the European Parliament)

22 Apr 2025 · Critical medicines act

Response to Targeted evaluation of Regulation (EU)2017/745 on Medical Devices and Regulation (EU)2017/746 on In Vitro Diagnostics

21 Mar 2025

Meeting with Angelika Niebler (Member of the European Parliament)

19 Feb 2025 · EU Pharma Policy

Meeting with Pierre Jouvet (Member of the European Parliament)

4 Nov 2024 · Présentation des activités de l'AMGEN en France

Meeting with Peter Van Kemseke (Cabinet of President Ursula von der Leyen)

10 Oct 2024 · EB Summit

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and 5 other interest representatives

23 Jan 2024 · Pharmaceutical Package (Regulation)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 8 other interest representatives

12 Dec 2023 · Directive on Medicinal products for human use

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

29 Aug 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

29 Aug 2023

Meeting with Deirdre Clune (Member of the European Parliament)

19 Jul 2023 · Pharmaceutical Package

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 11 other interest representatives

18 Jul 2023 · Directive on Medicinal products for human use

Meeting with Susana Solís Pérez (Member of the European Parliament, Shadow rapporteur)

10 Nov 2022 · EHDS

Response to Revision of Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC)

14 Feb 2022

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

6 Jan 2021

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

7 Jul 2020

Meeting with Ursula von der Leyen (President) and 2 other interest representatives

12 Jun 2020 · Videoconference CEO of Amgen and CEO of Teneo (Topic: Preparation of Global Pledging Summit on 27 June)

Meeting with Manuel Mateo Goyet (Cabinet of Commissioner Mariya Gabriel)

17 May 2018 · Digital Health